Apellis Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
CRESTWOOD, Ky. and CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition …